+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Autoinjectors Market 2021-2025- Product Image

Global Autoinjectors Market 2021-2025

  • ID: 5309592
  • Report
  • March 2021
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • Amgen Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Becton
  • Dickinson and Co.
  • Eli Lilly and Co.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Autoinjectors Market 2021-2025

The publisher has been monitoring the autoinjectors market and it is poised to grow by $ 82.91 bn during 2021-2025 progressing at a CAGR of 24% during the forecast period. The report on autoinjectors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergies and need for immediate care and growing popularity of injectable therapies. In addition, increasing prevalence of allergies and need for immediate care is anticipated to boost the growth of the market as well.

The autoinjectors market analysis includes application segment and geographical landscapes.

The autoinjectors market is segmented as below:

By Application
  • Anaphylaxis
  • Multiple sclerosis
  • Rheumatoid arthritis
  • Others
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the rise in commercial approvals of new products as one of the prime reasons driving the autoinjectors market growth during the next few years.

The report on autoinjectors market covers the following areas:
  • Autoinjectors market sizing
  • Autoinjectors market forecast
  • Autoinjectors market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoinjectors market vendors that include Amgen Inc., Antares Pharma Inc., Bayer AG, Becton, Dickinson and Co., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed Holding AG. Also, the autoinjectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Becton
  • Dickinson and Co.
  • Eli Lilly and Co.
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Application
  • Market segments
  • Comparison by Application
  • Anaphylaxis - Market size and forecast 2020-2025
  • Multiple sclerosis - Market size and forecast 2020-2025
  • Rheumatoid arthritis - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • Market opportunity by Application
Market Segmentation by End-user
  • Hospitals and clinics
  • Self-administration
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Impact of COVID-19 pandemic and recovery in the global market
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Amgen Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Ypsomed Holding AG
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ billion)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Application - Market share 2020-2025 (%)
  • Comparison by Application
  • Anaphylaxis - Market size and forecast 2020-2025 ($ billion)
  • Anaphylaxis - Year-over-year growth 2020-2025 (%)
  • Multiple sclerosis - Market size and forecast 2020-2025 ($ billion)
  • Multiple sclerosis - Year-over-year growth 2020-2025 (%)
  • Rheumatoid arthritis - Market size and forecast 2020-2025 ($ billion)
  • Rheumatoid arthritis - Year-over-year growth 2020-2025 (%)
  • Others - Market size and forecast 2020-2025 ($ billion)
  • Others - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Application
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ billion)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ billion)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ billion)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ billion)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ billion)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Amgen Inc. - Overview
  • Amgen Inc. - Business segments
  • Amgen Inc. - Key offerings
  • Amgen Inc. - Key customers
  • Amgen Inc. - Segment focus
  • Antares Pharma Inc. - Overview
  • Antares Pharma Inc. - Business segments
  • Antares Pharma Inc. - Key offerings
  • Antares Pharma Inc. - Key customers
  • Antares Pharma Inc. - Segment focus
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key offerings
  • Bayer AG - Key customers
  • Bayer AG - Segment focus
  • Becton, Dickinson and Co. - Overview
  • Becton, Dickinson and Co. - Business segments
  • Becton, Dickinson and Co. - Key offerings
  • Becton, Dickinson and Co. - Key customers
  • Becton, Dickinson and Co. - Segment focus
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Business segments
  • Eli Lilly and Co. - Key offerings
  • Eli Lilly and Co. - Key customers
  • Eli Lilly and Co. - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Johnson & Johnson - Overview
  • Johnson & Johnson - Business segments
  • Johnson & Johnson - Key offerings
  • Johnson & Johnson - Key customers
  • Johnson & Johnson - Segment focus
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Key customers
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Key customers
  • Viatris Inc. - Segment focus
  • Ypsomed Holding AG - Overview
  • Ypsomed Holding AG - Business segments
  • Ypsomed Holding AG - Key offerings
  • Ypsomed Holding AG - Key customers
  • Ypsomed Holding AG - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Becton
  • Dickinson and Co.
  • Eli Lilly and Co.
The publisher recognizes the following companies as the key players in the global autoinjectors market: Amgen Inc., Antares Pharma Inc., Bayer AG, Becton, Dickinson and Co., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed Holding AG.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rise in commercial approvals of new products.'

According to the report, one of the major drivers for this market is the increasing prevalence of allergies and need for immediate care.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Amgen Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Becton
  • Dickinson and Co.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Ypsomed Holding AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll